SOPHiA GENETICS announced that its CEO and Co-founder, Dr. Jurgi Camblong, will present at the NVIDIA GTC AI Conference in San Jose, California, on March 17, 2025. The session, titled 'Interpret Health Data With AI to Change the Future of Medicine,' will be broadcast virtually.
This presentation will expand on a previously announced collaboration involving SOPHiA GENETICS, Microsoft, and NVIDIA, focusing on a whole genome sequencing (WGS) analytical solution. The SOPHiA DDM™ Platform, hosted on Azure and powered by NVIDIA Parabricks, is designed to quickly process whole genomes to provide invaluable insights.
The company's participation in a prominent AI conference like NVIDIA GTC underscores its commitment to leveraging artificial intelligence to transform patient care. It also highlights its strategic partnerships with leading technology companies, reinforcing its position in data-driven medicine.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.